Key points are not available for this paper at this time.
Despite the wide range of treatment options available for depression, the response rates, remission rates, and quality-of-life results in this study show that most patients with a substantial degree of treatment resistance continue to have significant symptomatology and functional disability when receiving TAU.
Dünner et al. (Mon,) studied this question.